Company / Current Assets
Sonoma Pharmaceuticals, Inc. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$12.6M
FY2025
5-year range
$12.5M / $16.4M
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets returned to growth in FY2025 after 2 years of decline, reaching $13M.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of +0.4%.
Declined from $14M to $13M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, current assets increased 0.8% year-over-year.
- Peak current assets was recorded in FY2017.
- Lowest current assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | - | - |
| FY2025 | $12.6M | +0.8% |
| FY2024 | $12.5M | -9.1% |
| FY2023 | $13.8M | -16.0% |
| FY2022 | $16.4M | +26.6% |
| FY2021 | $13.0M | +4.8% |
| FY2020 | $12.4M | -0.9% |
| FY2019 | $12.5M | -23.1% |
| FY2018 | $16.3M | -28.2% |
| FY2017 | $22.6M | +75.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026